Neurona Therapeutics Stock
Neurona Therapeutics is a pre-clinical stage biotechnology company focused on the discovery of regenerative cell-based therapeutics to treat intractable neurological disease.
Sign up for SecondMarket® to view the market and buy or sell Neurona Therapeutics Stock
Buy + SellNeurona Therapeutics Funding
Sign up to gain insights into Neurona Therapeutics funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series F | Apr 03, 2025 | 102.00M | ||
| Series E | Feb 13, 2024 | 120.00M | ||
| Series D | Jun 22, 2021 | 41.50M | ||
| Series B | Feb 08, 2018 | 10.04M | ||
| Series A | Dec 28, 2016 | 21.22M | ||
| Series A | Dec 09, 2014 | 7.64M |
See Neurona Therapeutics Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Neurona Therapeutics Stock Valuation + Share Prices
View real-time Tape D® data on Neurona Therapeutics stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
Neurona Therapeutics Management Team
-
Co-Founder, Scientific Advisor
Auturo Alvarez-Buylla
-
Co-Founder, Scientific Advisor
Arnold Kriegstein
-
Board Member
Leo Guthart
-
Co-Founder, CEO, Board Member
Cory Nicholas
-
Chief Development Officer
Catherine Priest
-
Co-Founder, Scientific Advisor
John Rubenstein
-
Board Member
Tim Kutzkey
-
Board Member
Robert Tijan
-
CTO
Gautam Banik
-
CFO, Chief Business Officer
James Stutz
-
Chief Medical Officer
Manher Joshi
-
Board Member
Brad Margus
-
Board Member
Erica Whittaker
Neurona Therapeutics Major Investors
-
Fidelity
-
Soleus Capital Management
-
Column Group
-
Cormorant Asset Management
-
UCB
-
Willett Advisors
-
Lyfe Capital
-
SymBiosis
-
Sphera Funds Management
-
UC Investments (UCOP)
-
YK Bioventures
-
Ironfire Capital
-
Viking Global Investors
-
Spur Capital Partners
-
Schroders Capital
-
Ysios Capital Partners
-
Berkeley Frontier Fund
-
Topspin Partners
-
Euclidean Capital
-
Alexandria Venture Investments
Learn More About Neurona Therapeutics Stock
Buy Neurona Therapeutics Stock
01Neurona Therapeutics stock does not trade on public stock exchanges. Neurona Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Neurona Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Neurona Therapeutics Stock
02Neurona Therapeutics Stock does not trade on public stock exchanges. In order to sell Neurona Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Neurona Therapeutics Stock Price
03Neurona Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Neurona Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
Neurona Therapeutics Stock Ticker Symbol
04There is no ticker symbol for Neurona Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Neurona Therapeutics Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Neurona Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Neurona Therapeutics Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Neurona Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Neurona Therapeutics Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Neurona Therapeutics IPO
08Neurona Therapeutics is a private company and has not had an IPO. There is currently no Neurona Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Neurona Therapeutics IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell Neurona Therapeutics Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
